Tech Company Financing Transactions
Partillion Bioscience Funding Round
Partillion Bioscience closed a $5 million Seed venture capital round on 9/27/2023. Investors included private investors, ND Capital and Paladin Capital Group.
Transaction Overview
Company Name
Announced On
9/27/2023
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate its growth and launch new functional single-cell analysis and sorting product lines enabled by its proprietary Nanovial technology.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
570 Westwood Plaza Building 114
Los Angeles, CA 90095
USA
Los Angeles, CA 90095
USA
Phone
Undisclosed
Website
Email Address
Overview
Partillion Bioscience is an early stage life science company aiming to democratize advanced single-cell assays with its award-winning nanovial platform. Our novel platform allows the rapid compartmentalization and analysis of millions of single cells to probe biological function such as secreted proteins. The validated technology underpinning Partillion's products has been featured in notable journals such as Science Advances, Advanced Functional Materials, and Lab on Chip and received industry accolades, winning the 2020 SLAS Innovation Award.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joseph Rutte
Browse more venture capital transactions:
Prev: 9/27/2023: Scentian Bio venture capital transaction
Next: 9/27/2023: Breezit venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs